Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging

Circulation

Volumn 98, Issue 3, 1998, Pages 217-233

  Geskin, Gennady ^a   Kramer, Christopher M ^a,b   Rogers, Walter J ^a   Theobald, Therese M ^a   Pakstis, Diana ^a   Hu, Yong Lin ^a   Reichek, Nathaniel ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Magnetic resonance imaging; Mechanics; Myocardial contraction; Myocardial infarction; Stunning, myocardial

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DRUG EFFECT; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032555093     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.98.3.217     Document Type: Article

References (30)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
2. Carlos ME, Smart SC, Wynsen JC, Sagar KB. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation. 1997;95:1402-1410.
3. Pierard LA, De Lansheere CM, Berthe C, Rigo P, Kulbertus HA. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol. 1990;15:1021-1031.
4. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K, Bourdillon PDV, Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 1993;88:405-415.
5. Watada H, Ito H, Oh H, Masuyama T, Aburaya M, Hori M, Iwakura M, Higashino MY, Fujii K, Minamino T. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol. 1994;24:624-630.
6. Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A. Stress echocardiography and the human factor: the importance of being an expert. J Am Coll Cardiol. 1991;17:666-669.
7. Hoffman R, Lethen H, Marwick T, Arnese M, Fioretti P, Pingitore A, Picano E, Buck T, Erbel R, Flaschskampf FA, Hanrath P. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol. 1996;27:330-336.
8. Hansen TH, Segar DS. The use of dobutamine stress echocardiography for the determination of myocardial viability. Clin Cardiol. 1996;19:607-612.
9. Dendale PAC, Franken PR, Waldman G-J, De Moor DGE, Tombeur DAM, Block PFC, De Roos A. Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am Heart J. 1995;130: 134-140.
10. Zerhouni E, Parrish D, Rogers WJ, Yang A, Shapiro EP. Human heart: tagging with MR imaging. Radiology. 1988;169:59-64.
11. Axel L, Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology. 1989;171:841-845.
12. Clark N, Reichek N, Bergey P, Hoffman EA, Brownson D, Palmon L, Axel L. Normal segmental myocardial function: assessment by magnetic resonance imaging using spatial modulation of magnetization. Circulation. 1991;84:67-74.
13. Kramer CM, Rogers WJ, Theobald TM, Power TP, Petruolo S, Reichek N. Remote noninfarcted region dysfunction soon after first anterior myocardial infarction: a magnetic resonance tagging study. Circulation. 1996; 94:660-666.
14. Power T, Kramer CM, Shaffer AL, Theobald T, Petruolo S, Reichek N, Rogers WJ. Dobutamine magnetic resonance tissue tagging: normal left ventricular response. Am J Cardiol. 1997;80:1203-1207.
15. Uren NG, Crake T, Lefroy D, de Silva R, Davies G, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med. 1994;331:222-227.
16. Lieberman AN, Weiss JL, Jugdutt BI, Becker LC, Bulkley BH, Garrison JG, Hutchins GM, Kallman CA, Weisfeldt ML. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thinning to the extent of myocardial infarction in the dog. Circulation. 1981;63:739-746.
17. Meza MF, Kates MA, Barbee RW, Revall S, Perry B, Murgo JP, Cheirif J. Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from infarcted myocardium. J Am Coll Cardiol. 1997;29:974-984.
18. Sklenar J, Ismail S, Villanueva FS, Goodman NC, Glasheen WP, Kaul S. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion. Circulation. 1994;90:1502-1512.
19. Kaul S. There may be more to myocardial viability than meets the eye. Circulation. 1995;92:2790-2793.
20. Atalar E, McVeigh ER. Optimum tag thickness for the measurement of position with MRI. IEEE Trans Med Imaging. 1994;13:152-160.
21. Sayad DE, Willett DL, Hundley WG, Grayburn PA, Peshock RM. Dobutamine magnetic resonance imaging with myocardial tagging predicts quantitative improvement in regional function after revascularization. Circulation. 1995;92(suppl I):I-507. Abstract.
22. Cubukcu AA, Ridgway JP, Sivananthan UM, Cooke A, Nair UR, Tan LB. Detection of contractile reserve by tagged cine MRI during low-dose dobutamine infusion. Circulation. 1995;92(suppl I):I-509. Abstract.
23. Gorscan J, Strum DP, Mandarino WA, Gulati VK, Pinsky MR. Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiography. Circulation. 1997;95: 2423-2433.
24. Young AA, Imai H, Chang C, Axel L. Two-dimensional left ventricular deformation during systole using MRI with SPAMM. Circulation. 1994; 89:740-752.
25. Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N. Three-dimensional deformation in hypertrophic cardiomyopathy. Circulation. 1994;90:854-867.
26. Iliceto S, Galiuto L, Marchese A, Cavallari D, Colonna P, Biasco G, Rizzon P. Analysis of microvascular integrity, contractile reserve and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol. 1996;77:441-445.
27. Lima JAC, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation. 1995;92: 1117-1125.
28. Yakota C, Nonogi H, Miyazaki S, Miyazaki S, Goto Y, Maeno M, Daikoku S, Itoh A, Haze K, Yamada N. Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction. Am J Cardiol. 1995; 75:577-581.
29. Rogers WJ, Kramer CM, Geskin G, Hu Y-L, Theobald TM, Petruolo SM, Reichek N. Contrast enhanced MRI early after reperfused MI predicts late functional recovery. Circulation 1996;94(suppl I):I-541. Abstract.
30. Kramer CM, Rogers WJ, Geskin G, Power T, Theobald TM, Hu Y-L, Reichek N. Usefulness of magnetic resonance imaging early after acute myocardial infarction. Am J Cardiol. 1997;80:690-695.